GM
57
-6
CCI
39
9
L
67
3
LYB
44
3
GLW
82
3
V
40
4
PLD
58
2
ORLY
58
8
CTAS
27
3
CNX
48
4
FE
62
2
IFF
48
-2
COST
53
2
VFC
59
-2
LNC
40
-2
TXT
70
-2
QRVO
59
6
CVS
52
2
CME
59
4
KR
49
4
GM
57
-6
CCI
39
9
L
67
3
LYB
44
3
GLW
82
3
V
40
4
PLD
58
2
ORLY
58
8
CTAS
27
3
CNX
48
4
FE
62
2
IFF
48
-2
COST
53
2
VFC
59
-2
LNC
40
-2
TXT
70
-2
QRVO
59
6
CVS
52
2
CME
59
4
KR
49
4
Financhill
Back

Novonesis (Novozymes A/S) Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
71

NVZMY
Novonesis (Novozymes A/S)

Last Price:
$59.77
Seasonality Move:
6.76%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Buy
71
Novonesis (Novozymes A/S) (NVZMY) is a Buy

Is Novonesis (Novozymes A/S) a Buy, Sell or Hold?

  • The current Novonesis (Novozymes A/S) [NVZMY] share price is $59.77. The Score for NVZMY is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • NVZMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

NVZMY Stock Price Chart

What is Novonesis (Novozymes A/S)'s stock price today?

  • The Novonesis (Novozymes A/S) share price today is $59.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVZMY is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVZMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 61.12 Buy
Chaikin Money Flow: -13127 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.22 - 58.7) Buy
Bollinger Bands (100): (57.83 - 64.35) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

NVZMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.64 Buy
20-day SMA: 56.12 Buy
50-day SMA: 58.97 Buy
200-day SMA: 63.18 Sell
8-day EMA: 58.61 Buy
20-day EMA: 57.56 Buy
50-day EMA: 58.65 Buy
200-day EMA: 61.58 Sell

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

Novonesis (Novozymes A/S) Earnings Growth & NVZMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

Novonesis (Novozymes A/S) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):